Symrise AG (SY1):企業の財務・戦略的SWOT分析

◆英語タイトル:Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDING33326FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Ingredients
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Symrise AG (SY1) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Symrise AG (Symrise) is a provider of flavors and fragrances. The company develops, produces, and sells flavorings, fragrances, cosmetic active ingredients and raw materials, and functional ingredients and solutions. It provides biofunctional and bioactive ingredients and substances to the health and personal care sector. The company develops products from natural raw materials like vanilla, citrus fruits, onions, fish, meat, blossoms, and plant materials. Symrise serves perfume, cosmetics, food, pharma and nutritional supplements industries, and manufacturers of household products. The company has operational presence in the Europe, Africa, the Middle East, Asia Pacific, North America, and Latin America. Symrise is headquartered in Holzminden, Niedersachsen, Germany.

Symrise AG Key Recent Developments

Jul 24,2020: Symrise inaugurates L’appartement Étoile
Jun 18,2020: Michael König elected Chairman of the Supervisory Board of Symrise AG
May 26,2020: Three Symrise products win first prize at BSB Innovation Awards 2020
Mar 10,2020: Symrise successfully continues profitable growth
Mar 02,2020: Symrise receives international “A” rating from CDP for outstanding environmental protection

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Symrise AG – Key Facts
Symrise AG – Key Employees
Symrise AG – Key Employee Biographies
Symrise AG – Major Products and Services
Symrise AG – History
Symrise AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Symrise AG – Business Description
Business Segment: Flavor
Overview
Performance
Key Stats
Business Segment: Nutrition
Overview
Performance
Key Stats
Business Segment: Scent & Care
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific
Target Markets
Performance
Geographical Segment: EAME
Target Markets
Performance
Geographical Segment: Latin America
Target Markets
Performance
Geographical Segment: North America
Target Markets
Performance
R&D Overview
Symrise AG – Corporate Strategy
Symrise AG – SWOT Analysis
SWOT Analysis – Overview
Symrise AG – Strengths
Symrise AG – Weaknesses
Symrise AG – Opportunities
Symrise AG – Threats
Symrise AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Symrise AG, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jul 24, 2020: Symrise inaugurates L’appartement Étoile
Jun 18, 2020: Michael König elected Chairman of the Supervisory Board of Symrise AG
May 26, 2020: Three Symrise products win first prize at BSB Innovation Awards 2020
Mar 10, 2020: Symrise successfully continues profitable growth
Mar 02, 2020: Symrise receives international “A” rating from CDP for outstanding environmental protection
Jan 20, 2020: Symrise receives top score of A in international climate protection rating
Jan 20, 2020: Michael König appointed to Symrise Supervisory Board
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Symrise AG, Key Facts
Symrise AG, Key Employees
Symrise AG, Key Employee Biographies
Symrise AG, Major Products and Services
Symrise AG, History
Symrise AG, Subsidiaries
Symrise AG, Key Competitors
Symrise AG, Ratios based on current share price
Symrise AG, Annual Ratios
Symrise AG, Annual Ratios (Cont...1)
Symrise AG, Annual Ratios (Cont...2)
Symrise AG, Interim Ratios
Symrise AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Symrise AG (SY1):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Edion Corporation (2730):企業の財務・戦略的SWOT分析
    Edion Corporation (2730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bio Blast Pharma Ltd (ORPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bio Blast Pharma Ltd (Bioblast Pharma) is a clinical stage biotechnology company that discovers, delivers, and develops clinical therapies for patients with rare and ultra-rare genetic diseases. The company discovers and develops pipeline products using platforms such as cabaletta, a mutant …
  • Paymark:企業の戦略的SWOT分析
    Paymark - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Yapi Merkezi Holding Inc.
    Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report Summary Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • MiMedx Group Inc (MDXG):企業の製品パイプライン分析
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Alpiq Holding AG:企業の戦略的SWOT分析
    Alpiq Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Hartford HealthCare Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Hartford HealthCare Corp (HHC) is a healthcare service provider that offers clinical care, education and research services. The organization's services include behavioral and mental health, bone and joint care, cancer, cardiology and heart care, dermatology, diabetes and endocrinology, diges …
  • Seaboard Corporation:企業の戦略・SWOT・財務情報
    Seaboard Corporation - Strategy, SWOT and Corporate Finance Report Summary Seaboard Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Senhwa Biosciences Inc (6492):製薬・医療:M&Aディール及び事業提携情報
    Summary Senhwa Biosciences Inc (Senhwa) is a clinical stage drug development company that develops next generation DNA damage response drugs for the treatment of cancer. The company’s pipeline products include CX-5461 and CX-4945. Its CX-5461, a G4-stabilizing compound, is a Pol I inhibitor that tri …
  • Tesco Corporation:戦略・SWOT・企業財務分析
    Tesco Corporation - Strategy, SWOT and Corporate Finance Report Summary Tesco Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bollore SA (BOL):企業の財務・戦略的SWOT分析
    Bollore SA (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Halozyme Therapeutics Inc (HALO):製薬・医療:M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • Centerra Gold Inc.:企業の戦略・SWOT・財務分析
    Centerra Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Centerra Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Panhandle Oil and Gas Inc. (PHX)-石油・ガス分野:企業M&A・提携分析
    Summary Panhandle Oil and Gas Inc. (Panhandle) is an upstream oil and gas company that carries out exploration, development, production and sale of oil and natural gas. It is involved in the acquisition, management and development of non-operated oil and natural gas properties, including wells locat …
  • Siemens Ltd (SIEMENS):企業の財務・戦略的SWOT分析
    Siemens Ltd (SIEMENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • VTB Bank:戦略・SWOT・企業財務分析
    VTB Bank - Strategy, SWOT and Corporate Finance Report Summary VTB Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Global Orthopaedic Technology Pty Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Global Orthopaedic Technology Pty Ltd (Global) is a medical device company that designs and manufactures orthopaedic implants. The company offers orthopaedic implants for knee, hip and spine. Its hip products include global cup, bioball system, paragon stem, absolut cemented stem, and unisyn …
  • iTeos Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary iTeos Therapeutics SA (iTeos) is a biotechnology company that develops novel cancer immunotherapies. The company’s pipeline products include small molecule immunomodulators targeting IDO1, A2A, immune check points, STING agonist, and antibodies directed to TIGIT and Galectin 3. It also devel …
  • CPI Aerostructures, Inc.:企業の戦略・SWOT・財務分析
    CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report Summary CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sempra Energy (SRE):電力:M&Aディール及び事業提携情報
    Summary Sempra Energy (Sempra) is an energy-services holding company. Through its subsidiaries, the company invests in, develops, and operates energy infrastructure. It carries out utility operations, development of energy infrastructure and related services in countries including the US, Mexico, Ar …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆